Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
hospital-acquired infections (HAI)
Research
Synthetic antibiotic kills multidrug-resistant pathogens in mice
A synthetic antibiotic looks to be effective against deadly drug-resistant pathogens, boosting survival in mice with systemic and localized infection.
Helen Floersh
Feb 16, 2024 7:00am
Entasis antibiotic beats last resort treatment in phase 3 trial
Oct 19, 2021 10:35am
FDA clears 2 disposable endoscopes to help cut infection risks
May 24, 2021 12:29pm
FDA cites potential infection risks with urological endoscopes
Apr 2, 2021 9:35am
Cambridge Univ. develop DNA test for secondary COVID infections
Jan 15, 2021 11:53am
Affinivax banks $120M for vaccines against hospital superbugs
Apr 23, 2020 7:00am
